Method for simultaneously detecting functional components of various medicinal and edible substances by HPLC (High Performance Liquid Chromatography)

The functional components of multiple medicinal and food homologous substances are simultaneously measured through HPLC and gradient elution procedures, which solves the limitations of single component determination in the prior art, and achieves efficient and accurate multi-component detection, which is suitable for quality control and quality of traditional Chinese medicinal materials. evaluate.

CN119000931APending Publication Date: 2024-11-22JINHUI LIQUOR CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411115425.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the prior art, methods for detecting the functional components of medicinal and food homology substances are mostly single-component determination, with a narrow scope of application and low detection efficiency, so it is impossible to detect multiple components efficiently at the same time.

Method used

Using high performance liquid chromatography (HPLC) combined with UV detector, the separation and gradient elution procedures are used to achieve the effect of puerarin, rutin, chlorogenic acid, echinobacterin, muttonin, rohanfenin V, and ginsenoside Re The simultaneous determination of eight functional components such as dihydrobamate was performed, and the Agilent Eclipse XDB-C18 chromatography column, acetonitrile and phosphate aqueous mobile phase was established, gradient elution procedures and standard curves were achieved to achieve efficient and accurate quantitative analysis.

Benefits of technology

It has achieved simultaneous determination of the functional components of a variety of medicinal and food homology substances, with high efficiency, high accuracy, high sensitivity, wide application range, and is suitable for quality control and quality evaluation of traditional Chinese medicinal materials and their extracts.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119000931A_ABST
    Figure CN119000931A_ABST
Patent Text Reader

Abstract

The invention discloses a method for simultaneously detecting functional components of various medicinal and edible substances by utilizing HPLC (High Performance Liquid Chromatography), which relates to the field of food detection and comprises the following steps: dissolving a sample to be detected, and separating the sample by utilizing the HPLC. The optimal absorption wavelength is determined through spectrum scanning screening of various medicinal and edible substance functional components at 190-400 nm, and the optimal chromatographic condition is determined through four mobile phase system tests and 14 times of elution gradient screening. The method realizes simultaneous determination of eight functional components including puerarin, rutin, chlorogenic acid, echinacoside, verbascoside, mogroside V, ginsenoside Re and dihydromyricetin. The method has the characteristics of high efficiency, high accuracy and high sensitivity, provides a more convenient technical means for quality control and quality evaluation of traditional Chinese medicinal materials and extracts thereof, and has better practical value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of food detection, and in particular to a method for simultaneously detecting functional components of a plurality of medicine-food homologous substances by using HPLC. Background Art

[0002] Food and medicine substances refer to substances listed in the "Catalogue of Traditional Food and Chinese Medicinal Materials". Due to their rich efficacy and wide sources, they are widely used in the fields of health food. Many liquor companies use "food and medicine" Chinese medicinal materials and their extracts as the main production raw materials for the development of functional liquors such as dew wine and health wine.

[0003] In the Chinese Pharmacopoeia, puerarin, rutin, chlorogenic acid, echinacoside and verbascoside, mogroside V, and ginsenoside R are respectively used as important functional components and quality evaluation indicators of Pueraria lobata, Sophora japonica, honeysuckle, Cistanche deserticola, Momordica grosvenori, and ginseng. Among them, Pueraria lobata has a long history of being a medicine and food, and contains ingredients such as flavonoids, saponins, and triterpenes. Puerarin is a flavonoid compound extracted from Pueraria lobata, which has the pharmacological effects of improving heart function, reducing inflammatory response, protecting the liver, and improving cardiovascular and cerebrovascular diseases. Sophora japonica, as the first substance listed as a medicine and food, has the effects of cooling blood and stopping bleeding, clearing the liver and purging fire. Rutin is an important functional component of its function, which has anti-inflammatory, antibacterial and lipid-lowering effects. Honeysuckle is rich in a variety of pharmacological ingredients, including chlorogenic acid, linalool, volatile oil, etc., among which chlorogenic acid is one of the main antibacterial, anti-inflammatory, and antioxidant effective pharmacological ingredients of honeysuckle. Cistanche deserticola is known as the "desert ginseng" and has the effects of nourishing the kidney and strengthening yang, and enhancing immunity. The main active ingredients in the approved health foods containing Cistanche deserticola include echinacoside, verbascoside and crude polysaccharides. Monk fruit has the effects of clearing heat and moistening the lungs, and lubricating the intestines and relieving constipation. Current research mainly focuses on the active ingredients of glycosides. GB1886.77-2016 "National Food Safety Standard Food Additives Mogrosides" uses mogroside V as the main active ingredient and its content as a quality control indicator. Ginseng is known as the king of herbs. It has the effects of replenishing vital energy, restoring pulse and strengthening deficiency, nourishing the spleen and lungs, and promoting body fluid and nourishing blood. Saponins are one of the main active ingredients that exert its effects. Ginsenoside Re is an important functional ingredient in ginseng. Studies have found that it plays a prominent role in neuroinflammation and immune regulation. Hovenia dulcis is a typical Chinese herbal medicine for sobering up and protecting the liver, containing flavonoids, alkaloids, fatty acids and other active ingredients. Studies have reported that dihydromyricetin is the main active ingredient in Hovenia dulcis, which has antihypertensive, antioxidant, and antibacterial effects.

[0004] High performance liquid chromatography (HPLC) is currently the most widely used method for determining the functional components of food-drug homologous substances. Studies on the detection methods of puerarin, rutin, chlorogenic acid, echinacoside and verbascoside, mogroside V, ginsenoside Re and dihydromyricetin have been reported, but most of them are methods for the determination of single components, with a narrow scope of application and low detection efficiency. Summary of the invention

[0005] The object of the present invention is to provide a method for simultaneously detecting functional components of multiple medicinal and edible substances by HPLC, which can realize the simultaneous determination of the above-mentioned 8 functional components including puerarin, rutin, chlorogenic acid, echinacoside, verbascoside, mogroside V, ginsenoside Re and dihydromyricetin, and provide a more convenient technical means for quality control and quality evaluation of Chinese medicinal materials and their extracts, and has the characteristics of good versatility, wide application range, sensitivity and rapidity.

[0006] The embodiment of the present invention is achieved as follows:

[0007] A method for simultaneously detecting functional components of multiple medicinal and edible substances using HPLC, comprising:

[0008] After dissolving the sample containing multiple functional components of medicine and food homology, the sample is separated by HPLC, and the peaks of the functional components of the medicine and food homology at 205-215 nm are detected by ultraviolet detector;

[0009] Among them, the functional ingredients of medicine and food homologous substances include puerarin, rutin, chlorogenic acid, echinacoside, verbascoside, mogroside V, ginsenoside Re and dihydromyricetin.

[0010] Further, in other preferred embodiments of the present invention, the HPLC separation test conditions are:

[0011] The chromatographic column is Agilent Eclipse XDB-C18, the column size is 4.6×250 mm, the column temperature is 25~35℃, and the flow rate is 0.5~0.8 ml / min.

[0012] Furthermore, in other preferred embodiments of the present invention, the mobile phase for HPLC separation is acetonitrile and aqueous phosphoric acid solution.

[0013] Furthermore, in other preferred embodiments of the present invention, the concentration of the phosphoric acid aqueous solution is 0.05 wt % to 0.2 wt %.

[0014] Further, in other preferred embodiments of the present invention, HPLC separation adopts gradient elution, and the gradient elution procedure is as follows:

[0015]

[0016] Further, in other preferred embodiments of the present invention, the retention time of the functional components of each medicine and food homologous substance separated by HPLC is:

[0017] Puerarin 19-20min, rutin 25-26min, chlorogenic acid 17-18min, echinacoside 21-22min, verbascoside 26-27min, mogroside V31-32min, ginsenoside Re 33-34min.

[0018] Furthermore, in other preferred embodiments of the present invention, standard products of functional components of multiple medicinal and edible substances are respectively prepared into mixed standard solutions of multiple concentrations, and the samples to be tested are separated by HPLC, and the peaks at 205-215 nm are detected by an ultraviolet detector; a standard curve is established with mass concentration as the horizontal coordinate X and peak area as the vertical coordinate Y (as shown in the following table).

[0019]

[0020] Further, in other preferred embodiments of the present invention, the peak area of ​​each food-medicine homologous substance functional component measured in the sample to be tested is substituted into the linear equation to quantitatively obtain the mass concentration of each food-medicine homologous substance in the sample to be tested, and the detection limit and quantification of each food-medicine homologous substance are as follows:

[0021]

[0022] Furthermore, in other preferred embodiments of the present invention, the sample to be tested is dissolved with an alcohol solvent under the assistance of ultrasound, and after the dissolution is completed, it is filtered with a 0.22 μm microporous filter membrane and then tested by HPLC.

[0023] The beneficial effects of the embodiments of the present invention are:

[0024] The embodiment of the present invention provides a method for simultaneously detecting multiple functional components of food-medicine homology substances by using HPLC, wherein after dissolving the test samples of multiple functional components of food-medicine homology substances, the test samples are separated by using HPLC, and the peaks of multiple food-medicine homology substances at 205-215nm are detected by using an ultraviolet detector. By screening the separation conditions, the method can achieve the simultaneous determination of the above 8 functional components. The method has the characteristics of high efficiency, high accuracy and high sensitivity, and provides a more convenient technical means for the quality control and quality evaluation of Chinese medicinal materials and their extracts, and has better practical value. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.

[0026] Figure 1 The UV spectra of the 8 functional components of the medicinal and edible substances provided in Example 1 of the present invention, wherein A: chlorogenic acid; B: dihydromyricetin; C: ginsenoside Re; D: rutin; E: echinacoside; F: puerarin; G: verbascoside; H: mogroside V;

[0027] Figure 2 The chromatogram of the sample to be tested provided in Example 1 of the present invention;

[0028] Figure 3 The chromatogram of the sample to be tested provided in Comparative Example 1 of the present invention;

[0029] Figure 4 The chromatogram of the sample to be tested provided in Comparative Example 2 of the present invention;

[0030] Figure 5 The chromatogram of the sample to be tested provided in Comparative Example 3 of the present invention;

[0031] Figure 6 The chromatogram of the sample to be tested provided in Comparative Example 4 of the present invention;

[0032] Figure 7 The chromatogram of the sample to be tested provided in Comparative Example 5 of the present invention;

[0033] Figure 8 This is the chromatogram of the sample to be tested provided in Comparative Example 6 of the present invention. DETAILED DESCRIPTION

[0034] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0035] The main materials, reagents and instrument information of the embodiment design are as follows:

[0036] Samples: puerarin from kudzu root extract, rutin from Sophora japonica flower extract, chlorogenic acid from honeysuckle flower extract, echinacoside and verbascoside from Cistanche deserticola extract, mogroside V from Momordica grosvenori extract, ginsenoside Re from ginseng extract and dihydromyricetin from Hovenia dulcis fruit extract. All samples are commercially available.

[0037] Standards and reagents: Puerarin, rutin, chlorogenic acid, echinacoside, verbascoside, mogroside V, ginsenoside Re: purchased from China Food and Drug Inspection Institute; dihydromyricetin: purchased from Beijing Solebow Technology Co., Ltd.; methanol and acetonitrile (both chromatographically pure): purchased from Merck KGaA, Germany; phosphoric acid: purchased from Sinopharm Chemical Reagent Co., Ltd.; ultrapure water was used in the experiment.

[0038] Instruments and equipment: 1260lnfinity II Agilent high performance liquid chromatograph; Milli-Q ultrapure water instrument, Merck Chemical Technology (Shanghai) Co., Ltd.; electronic balance (one hundred thousandth), Sartorius Scientific Instrument (Beijing) Co., Ltd.; KQ5200 V ultrasonic cleaner, Kunshan Ultrasonic Instrument Co., Ltd.

[0039] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.

[0040] Example 1

[0041] This embodiment provides a method for simultaneously detecting functional components of multiple medicinal and edible substances using HPLC, comprising:

[0042] S1. Preparation of standard solution:

[0043] Accurately weigh 10.00 mg of puerarin, rutin, chlorogenic acid, echinacoside, verbascoside, mogroside V, ginsenoside Re and dihydromyricetin reference substances into a 10 mL volumetric flask, add methanol for ultrasonic dissolution, and dilute to the scale to prepare a 1000 mg / L standard stock solution.

[0044] Pipette appropriate amounts of 8 standard stock solutions respectively, dilute them in sequence, and prepare 5 mixed standard series working solutions with different mass concentrations.

[0045] S2. Selection of detection wavelength

[0046] The spectra of the above 8 standard solutions were scanned in the wavelength range of 190-400 nm using a UV detector. Figure 1The experiment found that puerarin and mogroside V had maximum absorption values ​​at 200nm and the strongest response; verbascoside, echinacoside and ginsenoside Re had maximum absorption values ​​at 205nm; the maximum absorption wavelength of dihydromyricetin was 210nm; the maximum absorption wavelength of chlorogenic acid and rutin was 220nm. Puerarin, rutin, chlorogenic acid, echinacoside, verbascoside, mogroside V, ginsenoside Re and dihydromyricetin were comprehensively selected to be determined simultaneously at a wavelength of 210nm.

[0047] S3. Preparation of standard curve

[0048] The mixed standard series solution prepared in step S1 was separated by HPLC, and the peaks of various medicinal and edible homologous substances at 210 nm were detected by ultraviolet detector.

[0049] The HPLC separation test conditions are as follows: chromatographic column Agilent Eclipse XDB-C18, chromatographic column size 4.6×250 mm, column temperature 30° C., flow rate 0.6 ml / min, injection volume 5 μL; mobile phase acetonitrile and 0.1 wt % phosphoric acid aqueous solution, gradient elution program as shown in Table 1:

[0050] Table 1. Gradient elution program

[0051]

[0052] The standard curve was established with mass concentration as the horizontal axis X and peak area as the vertical axis Y, and the linear regression equation was obtained. The standard solutions of 8 functional ingredients (medicinal and edible homologous substances) were appropriately diluted to obtain solutions of different concentrations. The detection limit was 3 times the signal-to-noise ratio (S / N), and the quantification limit was 10 times the signal-to-noise ratio. The results are shown in Table 2:

[0053] Table 2. Standard curve parameters for eight functional ingredients

[0054]

[0055] As can be seen from Table 2, the eight functional components have a good linear relationship within their respective mass concentration ranges, and the correlation coefficient (R 2 ) are all > 0.999.

[0056] S4. Precision test

[0057] The mixed standard solution of the same concentration was sampled 6 times continuously and the peak area was recorded. The measurement results are shown in Table 3.

[0058] Table 3. Results of precision test of eight functional components

[0059]

[0060] As can be seen from Table 3, the relative standard deviations (RSDs) of the peak area determination results of chlorogenic acid, puerarin, echinacoside, dihydromyricetin, rutin, verbascoside, mogroside V and ginsenoside Re are 0.10%, 0.11%, 0.41%, 0.18%, 0.14%, 0.16%, 0.21% and 0.11%, respectively, all less than 5%. The data are relatively consistent with low discreteness, indicating that the instrument has good precision.

[0061] S5. Sample content determination and spike recovery test

[0062] Take the sample to be tested, dissolve it with methanol under ultrasound assistance, pass it through a 0.22 μm microporous filter membrane, and test the sample to be tested according to the HPLC separation test conditions in step S3. The chromatogram obtained is as follows: Figure 2 In the sample to be tested, the spiked amount of each food-drug homology substance was set at three concentration levels: low, medium and high, and the spiked recovery rate was calculated. The test results are shown in Table 4.

[0063] Table 4. Test results of the samples to be tested

[0064]

[0065] As shown in Table 4, the chlorogenic acid content of honeysuckle extract was 5.7570 mg / L, the dihydromyricetin content of Hovenia dulcis extract was 32.6869 mg / L, the echinacoside and verbascoside contents of Cistanche deserticola extract were 23.8608 mg / L and 6.7236 mg / L, respectively, the puerarin content of Pueraria lobata extract was 79.1286 mg / L, the rutin content of Sophora japonica extract was 92.5780 mg / L, the mogroside V content of Momordica grosvenori extract was 50.6113 mg / L, and the ginsenoside Re content of ginseng extract was 21.3980 mg / L. The average recovery rates of the functional components were 102.78% for chlorogenic acid, 105.63% for dihydromyricetin, 107.00% for echinacoside, 109.87% for verbascoside, 102.05% for puerarin, 98.87% for rutin, 104.43% for mogroside V, and 95.49% for ginsenoside Re, indicating that the detection method has good accuracy.

[0066] Comparative Examples 1 to 3

[0067] This comparative example provides a method for simultaneously detecting functional components of multiple medicinal and edible substances using HPLC. The specific operating steps are basically similar to those of Example 1, except that the gradient elution procedures are different. The gradient elution procedures of Comparative Examples 1 to 3 are shown in Table 5.

[0068] Table 5. Gradient elution program for different comparative examples

[0069]

[0070]

[0071] The chromatogram obtained is as follows Figures 3 to 5 As shown. Figure 3 It can be seen that when the elution is performed in the manner of Comparative Example 1, the components cannot be effectively separated. Figure 4 It can be seen that when eluted by the method of comparative example 2, mogroside V and ginsenoside Re did not peak and were not eluted, and the elution effect of chlorogenic acid, puerarin, echinacoside and verbascoside was not ideal, they were not completely separated, double peaks appeared, and qualitative and quantitative analysis could not be performed. Figure 5 It can be seen that by eluting in the manner of Comparative Example 3, all eight components were eluted, the peak shapes of puerarin and echinacoside were improved, but verbascoside was still a double peak, and the peak shape of chlorogenic acid was poor. From the above, it can be seen that the setting of the gradient elution program plays an important role in the separation effect of the present invention.

[0072] Comparative Examples 4 to 6

[0073] This comparative example provides a method for simultaneously detecting multiple medicinal and edible substances using HPLC. The specific operation steps are basically similar to those of Example 1, except that different mobile phases are used. The mobile phases of Comparative Examples 4 to 6 are shown in Table 6.

[0074] Table 6. Mobile phases for different comparative examples

[0075] Mobile phase A Mobile phase B Comparative Example 4 Methanol water Comparative Example 5 Methanol 0.1wt% phosphoric acid aqueous solution Comparative Example 6 Acetonitrile water

[0076] The chromatogram obtained is as follows Figures 6 to 8 As shown. Figure 6 It can be seen from the figure that when methanol-water is used as the mobile phase, the baseline drifts and only dihydromyricetin peaks. Figure 7 It can be seen that when methanol-0.1% phosphoric acid aqueous solution is used as the mobile phase, dihydromyricetin and chlorogenic acid are eluted, and other components do not have peaks. In addition, the chromatographic peak shape of chlorogenic acid is poor, and quantitative analysis cannot be performed. Figure 8 It can be seen that when acetonitrile-water is used as the mobile phase, all seven components except chlorogenic acid are eluted, indicating that acetonitrile has a stronger elution ability than methanol. As can be seen from the above, the selection of the mobile phase has an important influence on the separation effect of the present invention.

[0077] In summary, the embodiment of the present invention provides a method for simultaneously detecting multiple functional components of food-medicine homology substances using HPLC, which dissolves the sample to be tested containing multiple food-medicine homology substances, separates the sample to be tested using HPLC, and detects the peaks of the functional components of the food-medicine homology substances at 205-215nm using an ultraviolet detector. Through the screening of separation conditions, this method can achieve the simultaneous determination of the above 8 functional components. This method has the characteristics of high efficiency, high accuracy, and high sensitivity, and provides a more convenient technical means for the quality control and quality evaluation of Chinese medicinal materials and their extracts, and has better practical value.

[0078] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for simultaneously detecting functional components of multiple medicinal and edible substances using HPLC, It is characterized in that include: After dissolving the sample to be tested containing multiple functional components of medicine and food homology substances, the sample to be tested is separated by HPLC, and the peaks of the multiple functional components of medicine and food homology substances at 205-215 nm are detected by an ultraviolet detector; Among them, the functional ingredients of the medicine-food homologous substances include puerarin, rutin, chlorogenic acid, echinacoside, verbascoside, mogroside V, ginsenoside Re, and dihydromyricetin.

2. The method according to claim 1, It is characterized in that HPLC separation test conditions are: The chromatographic column is Agilent Eclipse XDB-C18, the column size is 4.6×250 mm, the column temperature is 25~35℃, and the flow rate is 0.5~0.8 ml / min.

3. The method according to claim 2, It is characterized in that The mobile phase for HPLC separation was acetonitrile and aqueous phosphoric acid.

4. The method according to claim 3, It is characterized in that The concentration of the phosphoric acid aqueous solution is 0.05 wt % to 0.2 wt %.

5. The method according to claim 4, It is characterized in that HPLC separation uses gradient elution, and the gradient elution procedure is as follows:

6. The method according to claim 5, It is characterized in that The retention time of the functional components of each of the medicine and food homologous substances separated by HPLC is: Puerarin 19-20min, rutin 25-26min, chlorogenic acid 17-18min, echinacoside 21-22min, verbascoside 26-27min, mogroside V31-32min, ginsenoside Re 33-34min.

7. The method according to claim 6, It is characterized in that The standard products of the functional components of the various medicinal and edible substances were respectively prepared into mixed standard solutions of various concentrations, the samples to be tested were separated by HPLC, and the peaks at 205-215 nm were detected by an ultraviolet detector; a standard curve was established with mass concentration as the abscissa X and peak area as the ordinate Y; the standard curves of the various medicinal and edible substances were as follows:

8. The method according to claim 7, It is characterized in that Substitute the peak area of ​​each functional component of the food-medicine homologous substance measured in the sample to be tested into the linear equation to quantitatively obtain the mass concentration of each food-medicine homologous substance in the sample to be tested. The detection limit and quantification of each food-medicine homologous substance are as follows:

9. The method according to claim 8, It is characterized in that The sample to be tested is dissolved with an alcohol solvent under the assistance of ultrasound, filtered with a 0.22 μm microporous filter membrane after the dissolution is completed, and then tested by HPLC.